HuagongsheHuagongshe Chemistry Print Report · For research reference only
2-Bromo-4-chloro-1,3-thiazole → 3-(6-(3-((tert-Butyldimethylsilyl)oxy)-2-(2-(4-chlorothiazol-2-yl)-2-oxoethoxy)propyl)-1,3-dimethyl-2,4-dioxo-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-d]pyrimidin-5-yl)benzonitrile
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 2-Bromo-4-chloro-1,3-thiazole | HCID 15141964 | — |
| Reactant | 2-((1-((tert-Butyldimethylsilyl)oxy)-3-(5-(3-cyanophenyl)-1,3-dimethyl-2,4-dioxo-3,4-dihydro-1H-pyrrolo[3,4-d]pyrimidin-6(2H)-yl)propan-2-yl)oxy)-N-methoxy-N-methylacetamide | HCID 86722900 | — |
| Product | 3-(6-(3-((tert-Butyldimethylsilyl)oxy)-2-(2-(4-chlorothiazol-2-yl)-2-oxoethoxy)propyl)-1,3-dimethyl-2,4-dioxo-2,3,4,6-tetrahydro-1H-pyrrolo[3,4-d]pyrimidin-5-yl)benzonitrile | HCID 86722902 | — |
Reaction Steps
The title compound was prepared from 2-((1-((tert-butyldimethylsilyl)oxy)-3-(5-(3-cyanophenyl)-1,3-dimethyl-2,4-dioxo-3,4-dihydro-1H-pyrrolo[3,4-d]pyrimidin-6(2H)-yl)propan-2-yl)oxy)-N-methoxy-N-methylacetamide and 2-bromo-4-chlorothiazole analogously to Example 13, step 3;
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09303035B2 |
| Source dataset | uspto-grants-2016_04 |
| ORD ID | ord-ec753dc587ac4f639a9aed6737f7cf90 |
| Source note | uspto-grants-2016_04 |